Patents by Inventor David R. Bright
David R. Bright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 4933364Abstract: A process for promoting growth and feed efficiency in food producing mammals is provided by administering to such mammals, growth promoting amounts of a zinc complex of a polyether antibiotic selected from the group consisting of monensin, nigericin, salinomycin, narasin, noborotomycin A and B, SY-1, grisorixin, X-206, lonomycin, laidlomycin, mutalomycin, alborixin, lasalocid and lysocellin.Zinc complexes of this type are prepared by adding soluble zinc salt to a fermentation beer containing a polyether antibiotic to thereby form an insoluble, recoverable biomass containing the desired growth-promoting zinc complex for use in the process herein.Type: GrantFiled: January 29, 1988Date of Patent: June 12, 1990Assignee: International Minerals & Chemical Corp.Inventors: Richard E. Ivy, David R. Bright, Robert D. Williams
-
Patent number: 4904689Abstract: A process for promoting growth and feed efficiency in food producing animals is provided by administering to such animals, growth promoting amounts of certain forms of lysocellin, including the free acid and physiologically-acceptable salts thereof.Metal complexes of lysocellin can be prepared by adding the appropriate soluble metal salts to a fermentation beer containing lysocellin to thereby form an insoluble, recoverable biomass containing the desired growth-promoting metal salt complex of lysocellin for use in the process herein.Type: GrantFiled: July 19, 1988Date of Patent: February 27, 1990Assignee: International Minerals & Chemical Corp.Inventors: Jerome L. Martin, David R. Bright, Robert D. Williams, Vernon V. Young
-
Patent number: 4761426Abstract: A growth promoting and feed efficiency-enhancing amount of a lysocellin material selected from the group consisting of lysocellin, lysocellin free acid, and the physiologically acceptable salts thereof is administered to a food-producing animal selected from the group consisting of ruminants, swine and poultry in a process for promoting growth and enhancing feed efficiency of such a food-producing animal.Type: GrantFiled: August 24, 1984Date of Patent: August 2, 1988Assignee: International Minerals & Chemical Corp.Inventors: Jerome L. Martin, David R. Bright, Robert D. Williams, Vernon V. Young
-
Patent number: 4720548Abstract: Control of parasitic worm (helminth) infestations in warm-blooded animals including poultry, swine, cattle, sheep and goats by administering substituted quinoxaline adducts to infested animals. In particular, certain adducts of quinoxaline-1,4-dioxides are capable of eliminating ingestations of the pinworms Syphacia obscelata and Aspicularis tetraptera in mammals. Several of the compounds are also effective against the tapeworm Hymenolepsis nana in mammals.Type: GrantFiled: May 1, 1986Date of Patent: January 19, 1988Assignee: Angus Chemical CompanyInventors: Vernon V. Young, David R. Bright
-
Patent number: 4661593Abstract: Control of parasitic worm (helminth) infestations in warm-blooded animals including poultry, swine, cattle, sheep and goats by administering substituted quinoxaline adducts to infested animals. In particular, certain adducts of quinoxaline-1,4-dioxides are capable of eliminating ingestations of the pinworms Syphacia obcelata and Aspicularis tetraptera in mammals. Several of the compounds are also effective against the tapeworm Hymenolepsis nana in mammals.Type: GrantFiled: May 1, 1986Date of Patent: April 28, 1987Assignee: Angus Chemcial CompanyInventors: Vernon V. Young, David R. Bright
-
Patent number: 4658028Abstract: Control of parasitic worm (helminth) infestations in warm-blooded animals including poultry, swine, cattle, sheep and goats by administering substituted quinoxaline adducts to infested animals. In particular, certain adducts of quinoxaline-1,4-dioxides are capable of eliminating ingestations of the pinworms Syphacia obcelata and Aspicularis tetraptera in mammals. Several of the compounds are also effective against the tapeworm Hymenolepsis nana in mammals.Type: GrantFiled: May 1, 1986Date of Patent: April 14, 1987Assignee: Angus Chemical CompanyInventors: Vernon V. Young, David R. Bright
-
Patent number: 4656276Abstract: Control of parasitic worm (helminth) infestations in warm-blooded animals including poultry, swine, cattle, sheep and goats by administering substituted quinoxaline adducts to infested animals. In particular, certain adducts of quinoxaline-1,4-dioxides are capable of eliminating ingestations of the pinworms Syphacia obcelata and Aspicularis tetraptera in mammals. Several of the compounds are also effective against the tapeworm Hymenolepsis nana in mammals.Type: GrantFiled: May 1, 1986Date of Patent: April 7, 1987Assignee: Angus Chemical CompanyInventors: Vernon V. Young, David R. Bright
-
Patent number: 4654334Abstract: Manganese complexes of various monovalent and divalent polyether antibiotics are provided which act as coccidiostats and growth promoting agents when administered to food-producing animals such as cattle, sheep, swine and poultry. Soluble manganese salt is added to a fermentation beer containing the polyether antibiotics to form an insoluble, recoverable biomass containing the desired manganese antibiotic complex. This biomass, in a dried form, can be given orally to animals such as cattle, sheep, swine and poultry.The subject manganese complexes include: linear monovalent and divalent polyethers (monensin, nigericin, lasalocid, lysocellin, etc.); non-glycolic monovalent monoglycoside polyethers (septamycin, dianemycin, lenoremycin, carriomycin and antibiotic A-204); mononitrogen-containing divalent pyrrole ethers (calcimycin, X-14547, etc.); polynitrogen-containing divalent pyrrole ethers (A-23187, etc.); glycolic monovalent monoglycoside polyethers (etheromycin, etc.Type: GrantFiled: February 21, 1984Date of Patent: March 31, 1987Assignee: International Minerals & Chemical Corp.Inventors: Robert D. Williams, David R. Bright, Vernon V. Young, Jerome L. Martin
-
Patent number: 4629790Abstract: Control of parasitic worm (helminth) infestations in warm-blooded animals including poultry, swine, cattle, sheep and goats by administering substituted quinoxaline adducts to infested animals. In particular, certain adducts of quinoxaline-1,4-dioxides are capable of eliminating infestations of the pinworms Syphacia obvelata and Aspicularis tetraptera in mannals. Several of the compounds are also effective against the tapeworm Hymenolepsis nana in mammals.Type: GrantFiled: March 25, 1985Date of Patent: December 16, 1986Assignee: ANGUS Chemical CompanyInventors: Vernon V. Young, David R. Bright
-
Patent number: 4478935Abstract: Manganese complexes of various monovalent and divalent polyether antibiotics are provided which act as coccidiostats and growth promoting agents when administered to food-producing animals such as cattle, sheep, swine and poultry. Soluble manganese salt is added to a fermentation beer containing the polyether antibiotics to form an insoluble, recoverable biomass containing the desired manganese antibiotic complex. This biomass, in a dried form, can be given orally to animals such as cattle, sheep, swine and poultry.The subject manganese complexes include: linear monovalent and divalent polyethers (monensin, nigericin, lasalocid, lysocellin, etc.); non-glycolic monovalent monoglycoside polyethers (septamycin, dianemycin, lenoremycin, carriomycin and antibiotic A-204); mononitrogen-containing divalent pyrrole ethers (calcimycin, X-14547, etc.); polynitrogen-containing divalent pyrrole ethers (A-23187, etc.); glycolic monovalent monoglycoside polyethers (etheromycin, etc.Type: GrantFiled: September 20, 1982Date of Patent: October 23, 1984Assignee: International Minerals & Chemical Corp.Inventors: Robert D. Williams, David R. Bright, Vernon V. Young, Jerome L. Martin
-
Patent number: 4393041Abstract: An adsorbable fibrin excipient for active biochemical agents which enables controlled release of the biochemical agents when a fibrin pellet or other article containing the biochemical agent is implanted in an animal. Also contemplated are formable combinations of fibrin and other materials, such as lactose, to vary the absorption rate from the rate obtained using fibrin alone.Type: GrantFiled: April 25, 1980Date of Patent: July 12, 1983Assignees: International Minerals & Chemical Corp., International Minerals & Chemical Corp.Inventors: Ross G. Brown, David R. Bright, Robert D. Williams
-
Patent number: 4348389Abstract: Control of parasitic worm (helminth) infestations in warm-blooded animals including poultry, swine, cattle, sheep and goats by administering substituted quinoxaline adducts to infested animals. In particular, certain adducts of quinoxaline-1,4-dioxides are capable of eliminating infestations of the pinworms Syphacia obvelata and Aspicularis tetraptera in mammals. Several of the compounds are also effective against the tapeworm Hymenolepsis nana in mammals.Type: GrantFiled: August 7, 1980Date of Patent: September 7, 1982Assignee: International Minerals & Chemical Corp.Inventors: Vernon V. Young, David R. Bright
-
Patent number: 4271174Abstract: A method for prophylactically and therapeutically treating mammals for the bacterial aspects of shipping fever caused by Pasteurella species prior to exposure, during incubation or during the symptomatic phase comprising parenterally administering to the mammal cycloserine in a dose sufficient to alleviate symptoms of shipping fever.Type: GrantFiled: May 29, 1980Date of Patent: June 2, 1981Assignee: International Minerals & Chemical Corp.Inventors: David R. Bright, Robert D. Williams